Bowflex (BFXXQ) 10-Q 7 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	NAUTILUS, INC.
Entity Central Index Key	1078207
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Amendment Flag	FALSE
Entity Common Stock, Shares Outstanding		31,382,889

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$30,693	$45,206
Available-for-sale securities	51,390	26,984
Trade receivables, net of allowances of $36 and $108	16,816	26,260
Inventories	19,966	24,896
Prepaids and other current assets	5,342	6,987
Income taxes receivable	22	50
Deferred income tax assets	11,030	12,368
Total current assets	135,259	142,751
Property, plant and equipment, net	9,665	9,634
Goodwill	2,318	2,520
Other intangible assets, net	10,285	10,575
Long-term deferred income tax assets	4,797	9,546
Other assets	533	628
Total assets	162,857	175,654
Liabilities and Shareholders' Equity
Trade payables	26,829	47,574
Accrued liabilities	9,140	9,851
Warranty obligations, current portion	2,497	2,246
Total current liabilities	38,466	59,671
Income taxes payable, non-current	3,828	3,725
Other long-term liabilities	1,186	1,186
Total liabilities	43,480	64,582
Commitments and contingencies (Note 13)
Shareholders' equity:
Common stock - no par value, 75,000 shares authorized, 31,382 and 31,333 shares issued and outstanding	6,091	8,033
Retained earnings	114,079	103,347
Accumulated other comprehensive loss	-793	-308
Total shareholders' equity	119,377	111,072
Total liabilities and shareholders' equity	$162,857	$175,654

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified
Statement of Financial Position [Abstract]
Allowance for doubtful trade receivables	$36	$108
Common stock, par value (in dollars per share)	$0	$0
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	31,382,000	31,333,000
Common stock, shares outstanding	31,382,000	31,333,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Net sales	$96,239	$71,903
Cost of sales	42,350	33,422
Gross profit	53,889	38,481
Operating expenses:
Selling and marketing	28,399	21,774
General and administrative	5,578	5,803
Research and development	2,307	1,903
Total operating expenses	36,284	29,480
Operating income	17,605	9,001
Other income (expense):
Interest income	44	8
Interest expense	-5	-7
Other, net	-116	-61
Total other income (expense), net	-77	-60
Income from continuing operations before income taxes	17,528	8,941
Income tax provision	6,669	3,193
Income from continuing operations	10,859	5,748
Discontinued operations:
Loss from discontinued operations before income taxes	-153	-512
Income tax benefit from discontinued operations	-26	-138
Loss from discontinued operations	-127	-374
Net income	$10,732	$5,374
Earnings Per Share, Basic [Abstract]
Basic income per share from continuing operations (in dollars per share)	$0.35	$0.18
Basic loss per share from discontinued operation (in dollars per share)	$0	($0.01)
Basic net income per share (in dollars per share)	$0.34	$0.17
Earnings Per Share, Diluted [Abstract]
Diluted income per share from continuing operations (in dollars per share)	$0.34	$0.18
Diluted loss per share from discontinued operation (in dollars per share)	$0	($0.01)
Diluted net income per share (in dollars per share)	$0.34	$0.17
Shares used in per share calculations:
Basic (in shares)	31,396	31,172
Diluted (in shares)	31,767	31,550

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income	$10,732	$5,374
Other comprehensive loss:
Unrealized loss on marketable securities, net of income tax expense of $0 and $0	-1	-13
Foreign currency translation, net of income tax expense of $5 and $5	-484	-164
Comprehensive income	$10,247	$5,197

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Unrealized loss on marketable securities, tax expense	$0	$0
Foreign currency translation, tax expense	$5	$5

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Income from continuing operations	$10,859	$5,748
Loss from discontinued operations	-127	-374
Net income	10,732	5,374
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	910	865
Provision for (benefit from) allowance for doubtful accounts	-108	30
Inventory lower-of-cost-or-market adjustments	18	589
Stock-based compensation expense	301	265
(Gain) loss on asset dispositions	-2	1
Deferred income taxes, net of valuation allowance	6,102	2,321
Excess tax deficiency related to stock-based awards	2	102
Changes in operating assets and liabilities:
Trade receivables	9,719	11,752
Inventories	4,930	1,765
Prepaids and other current assets	1,763	2,617
Income taxes	27	356
Trade payables	-20,612	-9,830
Accrued liabilities, including warranty obligations	-298	-1,085
Net cash provided by operating activities	13,484	15,122
Cash flows from investing activities:
Purchases of available-for-sale securities	-30,440	-13,518
Proceeds from maturities of available-for-sale securities	3,680	0
Proceeds from sales of available-for-sale securities	2,354	0
Purchases of property, plant and equipment	-590	-521
Net cash used in investing activities	-24,996	-14,039
Cash flows from financing activities:
Proceeds from exercise of stock options	407	42
Payments for stock repurchases	-1,996	0
Tax payments related to stock award issuances	-652	0
Excess tax deficiency related to stock-based awards	-2	-102
Net cash used in financing activities	-2,243	-60
Effect of exchange rate changes on cash and cash equivalents	-758	33
Increase (decrease) in cash and cash equivalents	-14,513	1,056
Cash and cash equivalents:
Beginning of period	45,206	40,979
End of period	30,693	42,035
Supplemental disclosure of cash flow information:
Cash paid for interest	-6	-7
Cash paid for income taxes, net	-332	-95
Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid	$64	$0

General_Information

General Information	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General Information	GENERAL INFORMATION
	Basis of Consolidation and Presentation
	The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of Nautilus, Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation.
	The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014 (the “2014 Form 10-K”).
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Further information regarding significant estimates can be found in our 2014 Form 10-K.
	In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of March 31, 2015 and December 31, 2014, and our results of operations, comprehensive income and cash flows for the three months ended March 31, 2015 and 2014. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally and this seasonality can have a significant effect on operating results, inventory levels and working capital needs.
	Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations.
	New Accounting Pronouncements
	ASU 2015-02
	In February 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-02, “Consolidation (Topic 810).” ASU 2015-02 amends guidance regarding the consolidation of certain legal entities. ASU 2015-02 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, with early adoption permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We do not expect the adoption of ASU 2015-02 to have any effect on our financial position, results of operations or cash flows.
	ASU 2015-01
	In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20).” ASU 2015-01 simplifies income statement presentation by eliminating the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, with early adoption permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The adoption of ASU 2015-01 will not have any effect on our financial position, results of operations or cash flows.
	ASU 2014-12
	In June 2014, the FASB issued ASU No. 2014-12, "Compensation - Stock Compensation (Topic 718)". ASU No. 2014-12 addresses accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. ASU 2014-12 indicates that, in such situations, the performance target should be treated as a performance condition and, accordingly, the performance target should not be reflected in estimating the grant-date fair value of the award. Instead, compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.
	ASU 2014-09
	In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers". ASU 2014-09 clarifies the principles for recognizing revenue and develops a common revenue standard for U.S. GAAP and the International Accounting Standards Board that:
	• removes inconsistencies and weaknesses in revenue requirements;
	• provides a more robust framework for addressing revenue issues;
	• improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets;
	• provides more useful information to users of financial statements through improved disclosure requirements; and
	• simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer.
	ASU 2014-09 is effective for annual and interim periods beginning on or after December 15, 2016. While we do not expect the adoption of ASU 2014-09 to have a material effect on our business, we are still evaluating any potential impact that adoption of
	ASU 2014-09 may have on our financial position, results of operations or cash flows.
	ASU 2014-08
	In April 2014, the FASB issued ASU No. 2014-08, "Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity". ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, and amends the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 also enhances the convergence of the FASB’s and the International Accounting Standard Board’s reporting requirements for discontinued operations. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. We do not expect the adoption of ASU 2014-08 to have a material effect on our financial position, results of operations or cash flows.

Discontinued_Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	DISCONTINUED OPERATIONS
	There was no revenue related to discontinued operations for the three months ended March 31, 2015 or the year ended December 31, 2014. However, we continue to have legal and accounting expenses as we work with authorities on final deregistration of certain foreign entities and product liability expenses associated with product previously sold into the Commercial channel.
	The following table summarizes liabilities for exit costs related to discontinued operations, included in Accrued Liabilities and Other Long-Term Liabilities in our Condensed Consolidated Balance Sheets (in thousands):
		Facilities
		Leases
	Balance, December 31, 2014	$	573
	Adjustments	—
	Payments	(67		)
	Balance, March 31, 2015	$	506
	We expect the lease obligations to be paid out through 2016.

Fair_Value_Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS
	Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories:
	•	Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date;
	•	Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk; or observable market prices in markets with insufficient volume and/or infrequent transactions; and
	•	Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value.
	Assets measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 were as follows (in thousands):
			March 31, 2015
			Level 1		Level 2		Level 3		Total
	Cash Equivalents
	Money market funds		$	10,630	$	—	$	—	$	10,630
	Certificates of deposit(1)		—		245		—		245
	Commercial paper		—		1,000		—		1,000
	Corporate bonds		—		2,029		—		2,029
	Variable-rate demand notes		—		—		—		—
	Total Cash Equivalents		10,630		3,274		—		13,904
	Available-for-Sale Securities
	Certificates of deposit(1)		—		21,318		—		21,318
	Commercial paper		—		4,996		—		4,996
	Corporate bonds		—		25,076		—		25,076
	Total Available-for-Sale Securities		—		51,390		—		51,390
	Total assets measured at fair value		$	10,630	$	54,664	$	—	$	65,294
	(1) All certificates of deposit are within current FDIC insurance limits.
			31-Dec-14
			Level 1		Level 2		Level 3		Total
	Cash Equivalents
	Money market funds		$	2,591	$	—	$	—	$	2,591
	Certificates of deposit(1)		—		980		—		980
	Commercial paper		—		12,497		—		12,497
	Variable rate demand notes		—		8,000		—		8,000
	Total Cash Equivalents		2,591		21,477		—		24,068
	Available-for-Sale Securities
	Certificates of deposit(1)		—		14,202		—		14,202
	Corporate bonds		—		12,782		—		12,782
	Total Available-for-Sale Securities		—		26,984		—		26,984
	Total assets measured at fair value		$	2,591	$	48,461	$	—	$	51,052
	(1) All certificates of deposit are within current FDIC insurance limits.
	We did not have any liabilities measured at fair value on a recurring basis as of March 31, 2015 or December 31, 2014.
	We recognize transfers between levels at the actual date of the event or change in circumstance that caused the transfer.  There were no transfers between levels during the three months ended March 31, 2015, nor for the year ended December 31, 2014.
	We did not have any changes to our valuation techniques during the three months ended March 31, 2015.
	We classify our marketable securities as available-for-sale and, accordingly, record them at fair value. Level 1 investments valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 investments valuations are obtained from inputs, other than quoted market prices in active markets, that are directly or indirectly observable in the marketplace and quoted prices in markets with limited volume or infrequent transactions. The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in Comprehensive Income until realized.
	We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily Property, Plant and Equipment, Goodwill, Other Intangible Assets and certain other long-lived assets in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. We did not perform any valuations on assets or liabilities that are valued at fair value on a nonrecurring basis during the first quarter of 2015. During the fourth quarter of 2014, we performed our annual Goodwill and indefinite-lived trade names impairment valuations effective as of October 1, 2014. During the three months ended March 31, 2015 and the year ended December 31, 2014, we did not record any other-than-temporary impairments on our financial assets required to be measured at fair value on a nonrecurring basis.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Inventories	INVENTORIES
	Inventories are stated at the lower of cost or market, with cost determined based on the first-in, first-out method. We establish inventory allowances for excess, slow-moving and obsolete inventory based on inventory levels, expected product life and forecasted sales. Inventories are written down to market value based on historical demand, competitive factors, changes in technology and product lifecycles.
	Inventories consisted of the following (in thousands):
		As of
		March 31, 2015		December 31, 2014
	Finished goods	$	18,660	$	23,765
	Parts and components	1,306		1,131
	Total inventories	$	19,966	$	24,896

Property_Plant_and_Equipment

Property, Plant and Equipment	3 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	PROPERTY, PLANT AND EQUIPMENT
	Property, plant and equipment consisted of the following (in thousands):
		Estimated			As of
		Useful Life
		(in years)			March 31, 2015			December 31, 2014
	Automobiles	5			$	23		$	23
	Leasehold improvements	5	to	20	2,159			2,144
	Computer software and equipment	3	to	7	25,550			25,397
	Machinery and equipment	3	to	5	6,724			6,709
	Furniture and fixtures	5			1,104			1,108
	Work in progress(1)	N/A			861			421
	Total cost				36,421			35,802
	Accumulated depreciation				(26,756		)	(26,168		)
	Total property, plant and equipment, net				$	9,665		$	9,634
	(1) Work in progress includes production tooling and internal use software development.

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	GOODWILL AND OTHER INTANGIBLE ASSETS
	Goodwill
	All goodwill is assigned to our Direct reporting segment. The rollforward of goodwill was as follows (in thousands):
	Balance, January 1, 2014	$	2,740
	Currency exchange rate adjustment	(220		)
	Balance, December 31, 2014	2,520
	Currency exchange rate adjustment	(202		)
	Balance, March 31, 2015	$	2,318
	Other Intangible Assets
	Other intangible assets consisted of the following (in thousands):
		Estimated			As of
		Useful Life
		(in years)			March 31, 2015			December 31, 2014
	Other intangible assets:
	Indefinite-lived trademarks	N/A			$	9,052		$	9,052
	Patents	8	to	16	18,154			18,154
					27,206			27,206
	Accumulated amortization - patents				(16,921		)	(16,631		)
	Other intangible assets, net				$	10,285		$	10,575
	Amortization expense was as follows (in thousands):
			Three Months Ended March 31,
			2015			2014
	Patent amortization		$	290		$	510
	Future amortization of patents is as follows (in thousands):
	Remainder of 2015	$	538
	2016	430
	2017	143
	2018	65
	2019	35
	Thereafter	22
		$	1,233

Accrued_Liabilities

Accrued Liabilities	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Accrued Liabilities	ACCRUED LIABILITIES
	Accrued liabilities consisted of the following (in thousands):
		As of
		March 31, 2015		December 31, 2014
	Payroll and related liabilities	$	3,632	$	5,058
	Other	5,508		4,793
	Total accrued liabilities	$	9,140	$	9,851

Product_Warranties

Product Warranties	3 Months Ended
	Mar. 31, 2015
Product Warranties Disclosures [Abstract]
Product Warranties	PRODUCT WARRANTIES
	Our products carry limited, defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from thirty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in Cost of Sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly.
	Changes in our product warranty obligations were as follows (in thousands):
		Three Months Ended March 31,
		2015			2014
	Balance, beginning of period	$	2,246		$	1,638
	Accruals	815			921
	Payments	(564		)	(576		)
	Balance, end of period	$	2,497		$	1,983

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
	Accumulated other comprehensive income (loss), net of applicable taxes, reported on our Condensed Consolidated Balance Sheets consists of unrealized holding losses on available-for-sale securities and foreign currency translation adjustments. The following tables set forth the changes in accumulated other comprehensive income (loss), net of tax (in thousands):
		Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Loss
	Balance, December 31, 2014	$	(18	)	$	(290	)	$	(308	)
	Current period other comprehensive loss	(1		)	(484		)	(485		)
	Balance, March 31, 2015	$	(19	)	$	(774	)	$	(793	)
		Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
	Balance, December 31, 2013	$	—		$	244		$	244
	Current period other comprehensive loss	(13		)	(164		)	(177		)
	Balance, March 31, 2014	$	(13	)	$	80		$	67

Income_Per_Share

Income Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Income Per Share	INCOME PER SHARE
	Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. The weighted average numbers of shares outstanding used to compute income per share were as follows (in thousands):
		Three Months Ended March 31,
		2015	2014
	Shares used to calculate basic income per share	31,396	31,172
	Dilutive effect of outstanding stock options, performance stock units and restricted stock units	371	378
	Shares used to calculate diluted income per share	31,767	31,550
	The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share because, in the case of stock options, the average market price did not exceed the exercise price, and for the performance stock units, because these shares are subject to performance conditions that had not been met. These shares may be dilutive potential common shares in the future (in thousands):
		Three Months Ended March 31,
		2015	2014
	Stock options	25	320
	Performance stock units	163	84

Stock_Repurchase_Program

Stock Repurchase Program	3 Months Ended
	Mar. 31, 2015
Stockholders' Equity Note [Abstract]
Stock Repurchase Program	STOCK REPURCHASE PROGRAM
	On November 3, 2014, our Board of Directors approved a stock repurchase program that authorized us to repurchase up to $15.0 million of our outstanding common stock from time to time over a period of 24 months. The repurchase program expires November 3, 2016. Share repurchases will be funded with existing cash balances and repurchased shares will be retired and returned to unissued authorized shares. During the first quarter of 2015, we repurchased 133,877 shares at an average price of $14.91 per share for a total of $2.0 million, and, as of March 31, 2015, $13.0 million remains available for future repurchases.
	For additional information, see Issuer Purchases of Equity Securities at Part II, Item 2, "Unregistered Sales of Equity Securities and Use of Proceeds" in this Form 10-Q.

Segment_and_Enterprisewide_Inf

Segment and Enterprise-wide Information	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment and Enterprise-wide Information	SEGMENT AND ENTERPRISE-WIDE INFORMATION
	We have two reportable segments - Direct and Retail. Contribution is the measure of profit or loss, defined as Net Sales less product costs and directly attributable expenses. Directly attributable expenses include Selling and Marketing expenses, General and Administrative expenses, and Research and Development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily Accounts Receivable, Inventories, Goodwill and Other Intangible Assets. Unallocated assets primarily include Cash and Cash Equivalents, Available-for-Sale Securities, Prepaids and Other Current Assets, Deferred Income Tax Assets, Other Assets, shared information technology infrastructure, distribution centers and corporate headquarters. Capital expenditures directly attributable to the Direct and Retail segments were not significant in either period presented.
	Following is summary information by reportable segment (in thousands):
		Three Months Ended March 31,
		2015			2014
	Net sales:
	Direct	$	74,057		$	50,735
	Retail	21,290			20,103
	Unallocated royalty income	892			1,065
	Consolidated net sales	$	96,239		$	71,903
	Contribution:
	Direct	$	19,571		$	10,352
	Retail	1,500			2,509
	Unallocated royalty income	892			1,065
	Consolidated contribution	$	21,963		$	13,926
	Reconciliation of consolidated contribution to income from continuing operations:
	Consolidated contribution	$	21,963		$	13,926
	Amounts not directly related to segments:
	Operating expenses	(4,358		)	(4,925		)
	Other expense, net	(77		)	(60		)
	Income tax expense	(6,669		)	(3,193		)
	Income from continuing operations	$	10,859		$	5,748
	There was no material change in the allocation of assets by segment during the first three months of 2015 and, accordingly, assets by segment are not presented.
	For the three months ended March 31, 2015 and 2014, no customer represented 10.0% or more of total Net Sales.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES
	Guarantees, Commitments and Off-Balance Sheet Arrangements
	As of March 31, 2015, we had approximately $0.6 million in standby letters of credit with certain vendors with expiration dates through April 2016.
	We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of March 31, 2015, we had approximately $20.5 million in noncancelable market-based purchase obligations, primarily for inventory purchases expected to be received within the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses.
	In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.
	The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows and, therefore, no related liabilities were recorded as of March 31, 2015.
	Legal Matters
	In 2004, we were sued in the Southern District of New York by BioSig Instruments, Inc. for alleged patent infringement in connection with our incorporation of heart rate monitors into certain cardio products. No significant activity in the litigation occurred until 2008. In 2012, the United States District Court granted summary judgment to us on grounds that BioSig’s patents
	were invalid as a matter of law. BioSig appealed the grant of summary judgment and, in April 2013, the United States Court of Appeals for the Federal Circuit reversed the District Court’s decision on summary judgment and remanded the case to the District Court for further proceedings. On January 10, 2014, the U.S. Supreme Court granted our petition for a writ of certiorari to address the legal standard applied by the Federal Circuit in determining whether the patents may be valid under applicable law. The case was argued before the Supreme Court on April 28, 2014. By decision dated June 2, 2014, the Supreme Court unanimously reversed the Federal Circuit, holding that its standard of when a patent may be “indefinite” was incorrect and remanding to the Federal Circuit for reconsideration under the correct standard. The remand hearing in the Federal Circuit was held on October 29, 2014. By decision dated April 27, 2015, the same panel of the Federal Circuit affirmed its earlier reversal of the District Court’s decision. Unless we elect to petition for a rehearing en banc in the Federal Circuit or for further review in the United States Supreme Court the case will be returned to the District Court for further proceedings. We are currently evaluating these procedural options. We do not believe that our use of heart rate monitors utilized or purchased from third parties, and otherwise, infringes the BioSig patents.
	In August 2014, we initiated an arbitration proceeding under a 1999 license agreement pursuant to which we had licensed certain rights relating to our TreadClimber® products. We believe that our obligation to pay royalties under the license agreement ceased in the fourth quarter of 2013. The licensor disputes this and issued a notice under the contract claiming breach of the license agreement and asserting various remedies. We are seeking a declaratory ruling in the arbitration that we have performed all of our obligations under the license agreement, and that there is no continuing obligation for us to pay royalties. The licensor has asserted various counterclaims in the arbitration, including contract and intellectual property claims, and asserted various remedies, including termination of the license agreement. We replied to the counterclaim, denying the allegations and demanding remedies and asserting defenses. The arbitration is being administered by the American Arbitration Association and is in its preliminary stages. An arbitrator has been selected, however, a stay of the arbitration proceedings has been issued.
	In addition to the matters described above, from time to time, we may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to the eventual outcomes and losses which may be realized when one or more future events occur or fail to occur.
	Litigation and jury verdicts are, to some degree, inherently unpredictable, and, although we have determined that a loss is not probable in connection with any current legal proceeding, it is reasonably possible that a loss may be incurred in connection with proceedings to which we are a party. Assessment of whether incurrence of a loss is probable, or a reasonable possibility, in connection with a particular proceeding, and estimation of the loss, or a range of loss, involves complex judgments and numerous uncertainties. Management is unable to estimate a range of reasonably possible losses related to litigation in its early stages, especially when the damages sought are indeterminate, or the legal and factual basis for the relevant claims have not been developed with specificity. As such, zero liability is recorded as of March 31, 2015.
	We regularly monitor our estimated exposure to these contingencies and, as additional information becomes known, may change our estimates accordingly. We evaluate, on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would make a loss probable or reasonably possible, and whether the amount of a probable or reasonably possible loss is estimable. Among other factors, we evaluate the advice of internal and external counsel, the outcomes from similar litigation, current status of the lawsuits (including settlement initiatives), legislative developments and other factors. Due to the numerous variables associated with these judgments and assumptions, both the precision and reliability of the resulting estimates of the related loss contingencies are subject to substantial uncertainties.

Discontinued_Operations_Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Schedule of liabilities for exit costs related to discontinued operations	The following table summarizes liabilities for exit costs related to discontinued operations, included in Accrued Liabilities and Other Long-Term Liabilities in our Condensed Consolidated Balance Sheets (in thousands):
		Facilities
		Leases
	Balance, December 31, 2014	$	573
	Adjustments	—
	Payments	(67		)
	Balance, March 31, 2015	$	506

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Assets measured at fair value on a recurring basis	Assets measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 were as follows (in thousands):
		March 31, 2015
		Level 1		Level 2		Level 3		Total
	Cash Equivalents
	Money market funds	$	10,630	$	—	$	—	$	10,630
	Certificates of deposit(1)	—		245		—		245
	Commercial paper	—		1,000		—		1,000
	Corporate bonds	—		2,029		—		2,029
	Variable-rate demand notes	—		—		—		—
	Total Cash Equivalents	10,630		3,274		—		13,904
	Available-for-Sale Securities
	Certificates of deposit(1)	—		21,318		—		21,318
	Commercial paper	—		4,996		—		4,996
	Corporate bonds	—		25,076		—		25,076
	Total Available-for-Sale Securities	—		51,390		—		51,390
	Total assets measured at fair value	$	10,630	$	54,664	$	—	$	65,294
	(1) All certificates of deposit are within current FDIC insurance limits.
		31-Dec-14
		Level 1		Level 2		Level 3		Total
	Cash Equivalents
	Money market funds	$	2,591	$	—	$	—	$	2,591
	Certificates of deposit(1)	—		980		—		980
	Commercial paper	—		12,497		—		12,497
	Variable rate demand notes	—		8,000		—		8,000
	Total Cash Equivalents	2,591		21,477		—		24,068
	Available-for-Sale Securities
	Certificates of deposit(1)	—		14,202		—		14,202
	Corporate bonds	—		12,782		—		12,782
	Total Available-for-Sale Securities	—		26,984		—		26,984
	Total assets measured at fair value	$	2,591	$	48,461	$	—	$	51,052
	(1) All certificates of deposit are within current FDIC insurance limits.

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Schedule of Inventories, Net of Valuation Allowances	Inventories consisted of the following (in thousands):
		As of
		March 31, 2015		December 31, 2014
	Finished goods	$	18,660	$	23,765
	Parts and components	1,306		1,131
	Total inventories	$	19,966	$	24,896

Property_Plant_and_Equipment_T

Property, Plant, and Equipment (Tables)	3 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment consisted of the following (in thousands):
		Estimated			As of
		Useful Life
		(in years)			March 31, 2015			December 31, 2014
	Automobiles	5			$	23		$	23
	Leasehold improvements	5	to	20	2,159			2,144
	Computer software and equipment	3	to	7	25,550			25,397
	Machinery and equipment	3	to	5	6,724			6,709
	Furniture and fixtures	5			1,104			1,108
	Work in progress(1)	N/A			861			421
	Total cost				36,421			35,802
	Accumulated depreciation				(26,756		)	(26,168		)
	Total property, plant and equipment, net				$	9,665		$	9,634
	(1) Work in progress includes production tooling and internal use software development.

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill and Other Intangible Assets	The rollforward of goodwill was as follows (in thousands):
	Balance, January 1, 2014	$	2,740
	Currency exchange rate adjustment	(220		)
	Balance, December 31, 2014	2,520
	Currency exchange rate adjustment	(202		)
	Balance, March 31, 2015	$	2,318
	Other Intangible Assets
	Other intangible assets consisted of the following (in thousands):
		Estimated			As of
		Useful Life
		(in years)			March 31, 2015			December 31, 2014
	Other intangible assets:
	Indefinite-lived trademarks	N/A			$	9,052		$	9,052
	Patents	8	to	16	18,154			18,154
					27,206			27,206
	Accumulated amortization - patents				(16,921		)	(16,631		)
	Other intangible assets, net				$	10,285		$	10,575
Amortization Expense	Amortization expense was as follows (in thousands):
			Three Months Ended March 31,
			2015			2014
	Patent amortization		$	290		$	510
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Future amortization of patents is as follows (in thousands):
	Remainder of 2015	$	538
	2016	430
	2017	143
	2018	65
	2019	35
	Thereafter	22
		$	1,233

Accrued_Liabilities_Tables

Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands):
		As of
		March 31, 2015		December 31, 2014
	Payroll and related liabilities	$	3,632	$	5,058
	Other	5,508		4,793
	Total accrued liabilities	$	9,140	$	9,851

Product_Warranties_Tables

Product Warranties (Tables)	3 Months Ended
	Mar. 31, 2015
Product Warranties Disclosures [Abstract]
Schedule of Product Warranty Liability	Changes in our product warranty obligations were as follows (in thousands):
		Three Months Ended March 31,
		2015			2014
	Balance, beginning of period	$	2,246		$	1,638
	Accruals	815			921
	Payments	(564		)	(576		)
	Balance, end of period	$	2,497		$	1,983

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following tables set forth the changes in accumulated other comprehensive income (loss), net of tax (in thousands):
		Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Loss
	Balance, December 31, 2014	$	(18	)	$	(290	)	$	(308	)
	Current period other comprehensive loss	(1		)	(484		)	(485		)
	Balance, March 31, 2015	$	(19	)	$	(774	)	$	(793	)
		Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
	Balance, December 31, 2013	$	—		$	244		$	244
	Current period other comprehensive loss	(13		)	(164		)	(177		)
	Balance, March 31, 2014	$	(13	)	$	80		$	67

Income_Per_Share_Tables

Income Per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares Outstanding Used to Compute Income Per Share	The weighted average numbers of shares outstanding used to compute income per share were as follows (in thousands):
		Three Months Ended March 31,
		2015	2014
	Shares used to calculate basic income per share	31,396	31,172
	Dilutive effect of outstanding stock options, performance stock units and restricted stock units	371	378
	Shares used to calculate diluted income per share	31,767	31,550
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share because, in the case of stock options, the average market price did not exceed the exercise price, and for the performance stock units, because these shares are subject to performance conditions that had not been met. These shares may be dilutive potential common shares in the future (in thousands):
		Three Months Ended March 31,
		2015	2014
	Stock options	25	320
	Performance stock units	163	84

Segment_and_Enterprisewide_Inf1

Segment and Enterprise-wide Information (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Summary Information by Reportable Segments	Following is summary information by reportable segment (in thousands):
		Three Months Ended March 31,
		2015			2014
	Net sales:
	Direct	$	74,057		$	50,735
	Retail	21,290			20,103
	Unallocated royalty income	892			1,065
	Consolidated net sales	$	96,239		$	71,903
	Contribution:
	Direct	$	19,571		$	10,352
	Retail	1,500			2,509
	Unallocated royalty income	892			1,065
	Consolidated contribution	$	21,963		$	13,926
	Reconciliation of consolidated contribution to income from continuing operations:
	Consolidated contribution	$	21,963		$	13,926
	Amounts not directly related to segments:
	Operating expenses	(4,358		)	(4,925		)
	Other expense, net	(77		)	(60		)
	Income tax expense	(6,669		)	(3,193		)
	Income from continuing operations	$	10,859		$	5,748

Discontinued_Operations_Detail

Discontinued Operations (Details) (Facilities Leases, USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Facilities Leases
Restructuring Reserve [Roll Forward]
Balance, December 31, 2014	$573
Adjustments	0
Payments	-67
Balance, March 31, 2015	$506

Fair_Value_Measurements_Detail

Fair Value Measurements (Details) (Fair Value, Measurements, Recurring, USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	$13,904	$24,068
Available for Sale Securities	51,390	26,984
Assets measured at fair value	65,294	51,052
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	10,630	2,591
Available for Sale Securities	0	0
Assets measured at fair value	10,630	2,591
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	3,274	21,477
Available for Sale Securities	51,390	26,984
Assets measured at fair value	54,664	48,461
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0	0
Assets measured at fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	10,630	2,591
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	10,630	2,591
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	1,000	12,497
Available for Sale Securities	4,996
Commercial paper | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0
Commercial paper | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	1,000	12,497
Available for Sale Securities	4,996
Commercial paper | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0
Variable-rate demand notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	8,000
Variable-rate demand notes | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Variable-rate demand notes | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	8,000
Variable-rate demand notes | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	245	980
Available for Sale Securities	21,318	14,202
Certificates of deposit | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0	0
Certificates of deposit | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	245	980
Available for Sale Securities	21,318	14,202
Certificates of deposit | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0	0
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	2,029
Available for Sale Securities	25,076	12,782
Corporate bonds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0
Available for Sale Securities	0	0
Corporate bonds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	2,029
Available for Sale Securities	25,076	12,782
Corporate bonds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0
Available for Sale Securities	$0	$0

Inventories_Details

Inventories (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]
Finished goods	$18,660	$23,765
Parts and components	1,306	1,131
Total inventories	$19,966	$24,896

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$36,421	$35,802
Accumulated depreciation	-26,756	-26,168
Total property, plant and equipment, net	9,665	9,634
Automobiles
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	23	23
Estimated Useful Life (in years)	5 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	2,159	2,144
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	5 years
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	20 years
Computer software and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	25,550	25,397
Computer software and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	3 years
Computer software and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	7 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	6,724	6,709
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	5 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,104	1,108
Estimated Useful Life (in years)	5 years
Work in Progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$861	$421

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets Goodwill Roll Forward (Details) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Goodwill [Roll Forward]
Balance	$2,520	$2,740
Currency exchange rate adjustment	-202	-220
Balance	$2,318	$2,520

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Other intangible assets:
Indefinite-lived trademarks	9,052	$9,052
Patents	18,154	18,154
Total other intangible assets, gross	27,206	27,206
Accumulated amortization - patents	-16,921	-16,631
Other intangible assets, net	10,285	$10,575
Patents | Minimum
Other intangible assets:
Estimated Useful Life (in years)	8 years
Patents | Maximum
Other intangible assets:
Estimated Useful Life (in years)	16 years

Goodwill_and_Other_Intangible_4

Goodwill and Other Intangible Assets Patent amortization (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Patent amortization	$290	$510

Goodwill_and_Other_Intangible_5

Goodwill and Other Intangible Assets Future intangible amortization (Details) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2015	$538
2016	430
2017	143
2018	65
2019	35
Thereafter	22
Finite-Lived Intangible Assets, Net	$1,233

Accrued_Liabilities_Details

Accrued Liabilities (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Payables and Accruals [Abstract]
Payroll and related liabilities	$3,632	$5,058
Other	5,508	4,793
Total accrued liabilities	$9,140	$9,851

Product_Warranties_Details

Product Warranties (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Movement in Product Warranty Liability [Roll Forward]
Balance, beginning of period	$2,246	$1,638
Accruals	815	921
Payments	-564	-576
Balance, end of period	$2,497	$1,983
Minimum
Product Liability Contingency [Line Items]
Product warranty period	30 days

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Income (Loss) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	($308)	$244
Current period other comprehensive loss	-485	-177
Balance at end of period	-793	67
Unrealized Loss on Available-for-Sale Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	-18	0
Current period other comprehensive loss	-1	-13
Balance at end of period	-19	-13
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	-290	244
Current period other comprehensive loss	-484	-164
Balance at end of period	($774)	$80

Income_Per_Share_Details

Income Per Share (Details)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income per share:
Shares used to calculate basic income per share	31,396	31,172
Dilutive effect of outstanding stock options, performance stock units and restricted stock units	371	378
Shares used to calculate diluted income per share	31,767	31,550
Stock options
Income per share:
Anti-dilutive securities excluded from computation of diluted income per share	25	320
Performance stock units
Income per share:
Anti-dilutive securities excluded from computation of diluted income per share	163	84

Stock_Repurchase_Program_Detai

Stock Repurchase Program (Details) (Common Stock, USD $)	0 Months Ended	3 Months Ended
	Nov. 03, 2014	Mar. 31, 2015	Nov. 03, 2014
Common Stock
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, authorized amount	$15,000,000		$15,000,000
Stock repurchase program, period in force	24 months
Shares repurchased (shares)		133,877
Average cost per share repurchased		$14.91
Shares repurchased (value)		2,000,000
Remaining authorized repurchase amount		$13,000,000

Segment_and_Enterprisewide_Inf2

Segment and Enterprise-wide Information (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
	segment
Segment Reporting Information [Line Items]
Number of reportable segments	2
Net sales	$96,239	$71,903
Contribution	21,963	13,926
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Operating expenses	-36,284	-29,480
Income tax expense	-6,669	-3,193
Income from continuing operations	10,859	5,748
Direct
Segment Reporting Information [Line Items]
Net sales	74,057	50,735
Contribution	19,571	10,352
Retail
Segment Reporting Information [Line Items]
Net sales	21,290	20,103
Contribution	1,500	2,509
Unallocated royalty income
Segment Reporting Information [Line Items]
Net sales	892	1,065
Contribution	892	1,065
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Operating expenses	-4,358	-4,925
Other expense, net	-77	-60
Income tax expense	-6,669	-3,193
Income from continuing operations	$10,859	$5,748

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	Mar. 31, 2015
In Millions, unless otherwise specified
Commitments and Contingencies Disclosure [Abstract]
Standby letters of credit outstanding	$0.60
Non-cancelable market-based purchase obligation	$20.50